BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31354394)

  • 1. Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer.
    Schillaci O; Scimeca M; Toschi N; Bonfiglio R; Urbano N; Bonanno E
    Contrast Media Mol Imaging; 2019; 2019():9429761. PubMed ID: 31354394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
    Basu B; Basu S
    Cancer Biother Radiopharm; 2016 Apr; 31(3):75-84. PubMed ID: 27093341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized & Precision Medicine in Cancer: A Theranostic Approach.
    Choudhury P; Gupta M
    Curr Radiopharm; 2017 Nov; 10(3):166-170. PubMed ID: 28758574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of single-photon emission computed tomography and SPECT/computed tomography in oncologic imaging.
    Brandon D; Alazraki A; Halkar RK; Alazraki NP
    Semin Oncol; 2011 Feb; 38(1):87-108. PubMed ID: 21362518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging-guided theranostics and personalized medicine.
    Zhang H; Tian M; Li E; Fujibayashi Y; Shen LH; Yang DJ
    J Biomed Biotechnol; 2012; 2012():747416. PubMed ID: 22851886
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging Tumor Metastases with Molecular Probes.
    Qiao R; Zhu R; Gao M
    Curr Pharm Des; 2015; 21(42):6260-4. PubMed ID: 26503140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine.
    Schillaci O; Scimeca M; Trivigno D; Chiaravalloti A; Facchetti S; Anemona L; Bonfiglio R; Santeusanio G; Tancredi V; Bonanno E; Urbano N; Mauriello A
    Nucl Med Biol; 2019; 68-69():66-79. PubMed ID: 30770226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1925-33. PubMed ID: 23242718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bench to bedside molecular functional imaging in translational cancer medicine: to image or to imagine?
    Mahajan A; Goh V; Basu S; Vaish R; Weeks AJ; Thakur MH; Cook GJ
    Clin Radiol; 2015 Oct; 70(10):1060-82. PubMed ID: 26187890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannot Target What Cannot Be Seen: Molecular Imaging of Cancer Stem Cells.
    Marcu LG; Moghaddasi L; Bezak E
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-photon emission computed tomography tracers for predicting and monitoring cancer therapy.
    Cai J; Li F
    Curr Pharm Biotechnol; 2013; 14(7):693-707. PubMed ID: 24372237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I).
    Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A
    Mol Diagn Ther; 2019 Feb; 23(1):1-26. PubMed ID: 30411216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care.
    Mammatas LH; Verheul HM; Hendrikse NH; Yaqub M; Lammertsma AA; Menke-van der Houven van Oordt CW
    Cell Oncol (Dordr); 2015 Feb; 38(1):49-64. PubMed ID: 25248503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New advance in breast cancer pathology and imaging.
    Urbano N; Scimeca M; Bonfiglio R; Bonanno E; Schillaci O
    Future Oncol; 2019 Aug; 15(23):2707-2722. PubMed ID: 31339050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).
    Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A
    Mol Diagn Ther; 2019 Feb; 23(1):27-51. PubMed ID: 30387041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature.
    Chakravarty R; Hong H; Cai W
    Curr Drug Targets; 2015; 16(6):592-609. PubMed ID: 25182469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of hypoxia with radiolabelled agents.
    Mees G; Dierckx R; Vangestel C; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1674-86. PubMed ID: 19565239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides for in vivo target-specific cancer imaging.
    Ferro-Flores G; Ramírez Fde M; Meléndez-Alafort L; Santos-Cuevas CL
    Mini Rev Med Chem; 2010 Jan; 10(1):87-97. PubMed ID: 20380643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.